Dichlorotetrakis[2-(2-pyridinyl)phenyl]diiridium(III)>98.0%(HPLC)200mg

5-Amino-6-methyl-pyrimidine-2,4-diol, 97%, 10g

5-AMINO-1-ISOPROPYL-1H-PYRAZOLE-4-CARBONITRILE, 95.0%, 250mg

(S)-Methyl 6-amino-2-(((benzyloxy)carbonyl)amino)hexanoate hydrochloride, 95.0%, 25g

5-Ethyl-2-methoxyphenol, 95.0%, 250mg

Methyl 4-[(3-methoxy-3-oxopropyl)sulfanyl]-3-nitrobenzoate, 97+%, 250mg

6'-Bromo-2',3'-dihydro-1'H-spiro[cyclopropane-1,4'-isoquinolin]-1'-one, 98%, 250mg

(4-isopropyl-2-morpholinyl)acetic acid hydrochloride, 95.0%, 250mg

Rebastinib, 99.91%, 10mg

1,2,3,4-Tetraphenyl-1,3-cyclopentadiene>98.0%(GC)1g

(E)-2-(4-Methoxystyryl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g

N-(2-Chloro-5-nitrophenyl)-3-chloropropanamide, 98.0%, 10g

4-Chloro-1-(4-methylphenyl)-1-oxobutane, 95.0%, 250mg